Cargando…

Maternal 25(OH)D concentrations ≥40 ng/mL associated with 60% lower preterm birth risk among general obstetrical patients at an urban medical center

BACKGROUND: Given the high rate of preterm birth (PTB) nationwide and data from RCTs demonstrating risk reduction with vitamin D supplementation, the Medical University of South Carolina (MUSC) implemented a new standard of care for pregnant women to receive vitamin D testing and supplementation. OB...

Descripción completa

Detalles Bibliográficos
Autores principales:	McDonnell, Sharon L., Baggerly, Keith A., Baggerly, Carole A., Aliano, Jennifer L., French, Christine B., Baggerly, Leo L., Ebeling, Myla D., Rittenberg, Charles S., Goodier, Christopher G., Mateus Niño, Julio F., Wineland, Rebecca J., Newman, Roger B., Hollis, Bruce W., Wagner, Carol L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5524288/ https://www.ncbi.nlm.nih.gov/pubmed/28738090 http://dx.doi.org/10.1371/journal.pone.0180483

Ejemplares similares

Breast cancer risk markedly lower with serum 25-hydroxyvitamin D concentrations ≥60 vs <20 ng/ml (150 vs 50 nmol/L): Pooled analysis of two randomized trials and a prospective cohort
por: McDonnell, Sharon L., et al.
Publicado: (2018)

Serum 25-Hydroxyvitamin D Concentrations ≥40 ng/ml Are Associated with >65% Lower Cancer Risk: Pooled Analysis of Randomized Trial and Prospective Cohort Study
por: McDonnell, Sharon L., et al.
Publicado: (2016)

Correction: Serum 25-Hydroxyvitamin D Concentrations ≥40 ng/ml Are Associated with >65% Lower Cancer Risk: Pooled Analysis of Randomized Trial and Prospective Cohort Study
por: McDonnell, Sharon L., et al.
Publicado: (2018)

Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths
por: Grant, William B., et al.
Publicado: (2020)

Letter to Veugelers, P.J. and Ekwaru, J.P., A Statistical Error in the Estimation of the Recommended Dietary Allowance for Vitamin D. Nutrients 2014, 6, 4472–4475; doi:10.3390/nu6104472
por: Heaney, Robert, et al.
Publicado: (2015)

Reply: “Vitamin D Supplementation in Influenza and COVID-19 Infections. Comment on: Evidence That Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths Nutrients 2020, 12(4), 988”
por: Grant, William B., et al.
Publicado: (2020)

Sunlight and Vitamin D: Necessary for Public Health
por: Baggerly, Carole A., et al.
Publicado: (2015)

A Novel Approach Localizes the Association of Vitamin D Status With Insulin Resistance to One Region of the 25-Hydroxyvitamin D Continuum(1)(2)
por: Heaney, Robert P., et al.
Publicado: (2013)

Bias, Randomization, and Ovarian Proteomic Data: A Reply to “Producers and Consumers”
por: Baggerly, Keith A., et al.
Publicado: (2007)

Surface Adjustment of Reverse Phase Protein Arrays using Positive Control Spots
por: Neeley, E. Shannon, et al.
Publicado: (2012)

Overdispersed logistic regression for SAGE: Modelling multiple groups and covariates
por: Baggerly, Keith A, et al.
Publicado: (2004)

Protein and phosphoprotein levels in glioma and adenocarcinoma cell lines grown in normoxia and hypoxia in monolayer and three-dimensional cultures
por: Levin, Victor A, et al.
Publicado: (2012)

Metabolic Shifts Induced by Fatty Acid Synthase Inhibitor Orlistat in Non-small Cell Lung Carcinoma Cells Provide Novel Pharmacodynamic Biomarkers for Positron Emission Tomography and Magnetic Resonance Spectroscopy
por: Sankaranarayanapillai, Madhuri, et al.
Publicado: (2012)

illuminaio: An open source IDAT parsing tool for Illumina microarrays
por: Smith, Mike L, et al.
Publicado: (2013)

Patients with COVID-19 pneumonia with 25(OH)D levels lower than 12 ng/ml are at increased risk of death
por: Smaha, Juraj, et al.
Publicado: (2022)

Understanding the characteristics of mass spectrometry data through the use of simulation
por: Coombes, Kevin R., et al.
Publicado: (2007)

Genome-Wide Hypomethylation in Head and Neck Cancer Is More Pronounced in HPV-Negative Tumors and Is Associated with Genomic Instability
por: Richards, Kristy L., et al.
Publicado: (2009)

Immune cell profiling in cancer: molecular approaches to cell-specific identification
por: Lyons, Yasmin A., et al.
Publicado: (2017)

Surface PD-L1, E-cadherin, CD24, and VEGFR2 as markers of epithelial cancer stem cells associated with rapid tumorigenesis
por: Jinesh, Goodwin G., et al.
Publicado: (2017)

The likelihood of having serum level of PSA of ≥4.0 ng/mL and ≥10.0 ng/mL in non-obese and obese Nigerian men with LUTS
por: Adegun, Patrick Temi, et al.
Publicado: (2015)

Optimized Prediction of Extreme Treatment Outcomes in Ovarian Cancer
por: Misganaw, Burook, et al.
Publicado: (2016)

Evidence That Increasing Serum 25(OH)D Concentrations to 30 ng/mL in the Kingdom of Saudi Arabia and the United Arab Emirates Could Greatly Improve Health Outcomes
por: Grant, William B., et al.
Publicado: (2023)

Gene expression signature of estrogen receptor α status in breast cancer
por: Abba, Martín C, et al.
Publicado: (2005)

Obtaining reliable information from minute amounts of RNA using cDNA microarrays
por: Hu, Limei, et al.
Publicado: (2002)

Sources of nonlinearity in cDNA microarray expression measurements
por: Ramdas, Latha, et al.
Publicado: (2001)

Global analysis of aberrant pre-mRNA splicing in glioblastoma using exon expression arrays
por: Cheung, Hannah C, et al.
Publicado: (2008)

Clinical utility of serum folate measurement in tertiary care patients: Argument for revising reference range for serum folate from 3.0 ng/mL to 13.0 ng/mL
por: Singh, Gurmukh, et al.
Publicado: (2015)

Combining clinical parameters and multiparametric magnetic resonance imaging to stratify biopsy-naïve men for an optimum diagnostic strategy with prostate-specific antigen 4 ng ml(−1) to 10 ng ml(−1)
por: Zhang, Chi-Chen, et al.
Publicado: (2022)

Exploring parallel MPI fault tolerance mechanisms for phylogenetic inference with RAxML-NG
por: Hübner, Lukas, et al.
Publicado: (2021)

Integrated MicroRNA–mRNA Profiling Identifies Oncostatin M as a Marker of Mesenchymal-Like ER-Negative/HER2-Negative Breast Cancer
por: Bottai, Giulia, et al.
Publicado: (2017)

Is it suitable to eliminate bone scan for prostate cancer patients with PSA ≤ 20 ng/mL?
por: Lee, Seung Hwan, et al.
Publicado: (2011)

PSA density improves the rate of prostate cancer detection in Chinese men with a PSA between 2.5–10.0 ng ml(-1) and 10.1–20.0 ng ml(-1): a multicenter study
por: Lin, Yu-Rong, et al.
Publicado: (2015)

Exposure to a Vitamin D Best Practices Toolkit, Model, and E-Tools Increases Knowledge, Confidence, and the Translation of Research to Public Health and Practice †
por: Sanford, Beth S., et al.
Publicado: (2023)

Radical Prostatectomy as a First-Line Treatment in Patients with Initial PSA >20 ng/mL
por: Hinev, Alexander I., et al.
Publicado: (2012)

Stromal Tumor of Uncertain Malignant Potential (STUMP) With PSA >500 ng/ml: A Case Report
por: Johnson, Michael H., et al.
Publicado: (2015)

The Chances of Subsequent Cancer Detection in Patients with a PSA > 20 ng/ml and an Initial Negative Biopsy
por: Shaida, Nadeem, et al.
Publicado: (2009)

Prognosis of prostate cancer with initial prostate-specific antigen >1,000 ng/mL at diagnosis
por: Kan, Hung-Cheng, et al.
Publicado: (2017)

RAxML-NG: a fast, scalable and user-friendly tool for maximum likelihood phylogenetic inference
por: Kozlov, Alexey M, et al.
Publicado: (2019)

Adaptive RAxML-NG: Accelerating Phylogenetic Inference under Maximum Likelihood using Dataset Difficulty
por: Togkousidis, Anastasis, et al.
Publicado: (2023)

Correction: Transcriptomic changes in human breast cancer progression as determined by serial analysis of gene expression
por: Abba, Martin C, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_oc5oi1b2jlq6lg6s9gu8nug24b